Zoladex-10.8mg-Solution-SE-IS-ING

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Ingredient: Zoladex-10.8mg-Solution-SE-IS-ING

Generated Narrative: Ingredient Zoladex-10.8mg-Solution-SE-IS-ING

status: Active

for:

MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001699-00012377,http://ema.europa.eu/fhir/eurdId#1562; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Implant in pre-filled syringe; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = L02AE03
ManufacturedItemDefinition: status = active; manufacturedDoseForm = Implant in pre-filled syringe; unitOfPresentation = 200000002124
AdministrableProductDefinition: status = active; administrableDoseForm = Implant

role: Active

substance
Codes
- Concept
* Goserelin acetate
strength
concentration: quantity sufficient (Details: 100000000008 code100000165006 = '100000165006')/1 dose (Details: 100000110633 code200000025238 = '200000025238')
referenceStrength
Substances
- Concept
* Goserelin
strength: 10.8 milligram(s) (Details: 100000110633 code100000110655 = '100000110655')/1 dose (Details: 100000110633 code200000025238 = '200000025238')